Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Inshasi · SciRah

Researcher profile · Semantic Scholar

J. Inshasi

Share profile

J. Inshasi — researcher profile on SciRah

h-index: 18
Works: 133
Citations: 1,212

Most-cited papers

Consensus recommendations for the diagnosis and treatment of multiple sclerosis: 2019 revisions to the MENACTRIMS guidelines.
B. Yamout, M. Sahraian, S. Bohlega, M. Aljumah +15 more
2020Multiple Sclerosis and Related Disorders86 citations
Semantic Scholar
Consensus recommendations for diagnosis and treatment of Multiple Sclerosis: 2023 revision of the MENACTRIMS guidelines.
B. Yamout, M. Aljumah, M. Sahraian, Y. Almalik +17 more
2024Multiple Sclerosis and Related Disorders63 citations
Semantic Scholar
Pregnancy and the Use of Disease-Modifying Therapies in Patients with Multiple Sclerosis: Benefits versus Risks
R. Alroughani, A. Altıntaş, M. A. Al Jumah, M. Sahraian +14 more
2016Multiple Sclerosis International49 citations Open access
Semantic Scholar
Consensus recommendations for the diagnosis and treatment of multiple sclerosis: the Middle East North Africa Committee for Treatment and Research In Multiple Sclerosis (MENACTRIMS)
B. Yamout, R. Alroughani, M. Aljumah, R. Goueider +12 more
2015Current Medical Research and Opinion34 citations
Semantic Scholar
Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review
I. Alsharoqi, M. Aljumah, S. Bohlega, C. Boz +12 more
2020Neurological Therapeutics30 citations Open access
Semantic Scholar
An Overview of High-Efficacy Drugs for Multiple Sclerosis: Gulf Region Expert Opinion
R. Alroughani, J. Inshasi, D. Deleu, J. Al-Hashel +7 more
2019Neurological Therapeutics29 citations Open access
Semantic Scholar
MENACTRIMS practice guideline for COVID-19 vaccination in patients with multiple sclerosis
B. Yamout, M. Zakaria, J. Inshasi, M. Aljumah +5 more
2021Multiple Sclerosis and Related Disorders27 citations Open access
Semantic Scholar
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
R. Alroughani, J. Inshasi, A. Al-Asmi, Jaber Alkhabouri +6 more
2020Neurological Therapeutics26 citations Open access
Semantic Scholar
Effectiveness, safety and health-related quality of life of multiple sclerosis patients treated with fingolimod: results from a 12-month, real-world, observational PERFORMS study in the Middle East
A. Achiron, H. Aref, J. Inshasi, M. Harb +4 more
2017BMC Neurology24 citations Open access
Semantic Scholar
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis
T. Spelman, G. Simoneau, R. Hyde, R. Kuhelj +19 more
2024Neurology19 citations Open access
Semantic Scholar
INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin
V. P. Misra, C. Colosimo, D. Charles, Tae Mo Chung +112 more
2017Journal of Neurology19 citations Open access
Semantic Scholar
Alemtuzumab provides durable improvements in clinical outcomes in treatment-naive patients with active relapsing-remitting multiple sclerosis over 6 years in the absence of continuous treatment (CARE-MS I).
A. Coles, A. Boyko, J. Cohen, J. de Sèze +12 more
201619 citations
Semantic Scholar
Rescue treatment in patients with poorly responsive Guillain–Barre syndrome
A. Alboudi, Pournamy Sarathchandran, Samar Sameer Geblawi, D. Kayed +4 more
2019SAGE Open Medicine18 citations Open access
Semantic Scholar
Revisiting Hemicraniectomy: Late Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke and the Role of Infarct Growth Rate
Saddat Kamran, N. Akhtar, A. Salam, A. Alboudi +6 more
2017Stroke Research and Treatment18 citations Open access
Semantic Scholar
Mycoplasma pneumoniae infection presenting as stroke and meningoencephalitis with aortic and subclavian aneurysms without pulmonary involvement
Pournamy Sarathchandran, A. Almadani, A. Alboudi, J. Inshasi
2018BMJ Case Reports16 citations Open access
Semantic Scholar
Prediction of infarction volume and infarction growth rate in acute ischemic stroke
Saadat Kamran, N. Akhtar, A. Alboudi, Kainat Kamran +5 more
2017Scientific Reports15 citations Open access
Semantic Scholar
Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
C. Daruwalla, V. Shaygannejad, S. Ozakbas, E. Havrdová +88 more
2023Multiple Sclerosis14 citations Open access
Semantic Scholar
Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry.
E. Shosha, A. Al Asmi, E. Nasim, J. Inshasi +26 more
2020Multiple Sclerosis and Related Disorders14 citations
Semantic Scholar
Predictors of In-Hospital Mortality after Decompressive Hemicraniectomy for Malignant Ischemic Stroke.
Saadat Kamran, A. Salam, N. Akhtar, A. Alboudi +8 more
2017Journal of Stroke & Cerebrovascular Diseases14 citations
Semantic Scholar
Utilization of Multiple Sclerosis Therapies in the Middle East Over a Decade: 2009–2018
N. Moradi, S. Sharmin, C. Malpas, S. Ozakbas +13 more
2021CNS Drugs12 citations
Semantic Scholar
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
T. Spelman, M. Magyari, H. Butzkueven, A. van der Walt +52 more
2023Frontiers in Neurology10 citations Open access
Semantic Scholar
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity
R. Alroughani, J. Inshasi, A. Al-Asmi, Abdulradha Alqallaf +7 more
2020Postgraduate medicine10 citations Open access
Semantic Scholar
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19
J. Inshasi, R. Alroughani, A. Al-Asmi, J. Alkhaboury +7 more
2021Neurological Therapeutics9 citations Open access
Semantic Scholar
Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies
Jiwon Oh, S. Vukusic, K. Tiel‐Wilck, J. Inshasi +5 more
2021Journal of Central Nervous System Disease9 citations Open access
Semantic Scholar
High-efficacy therapies for relapsing-remitting multiple sclerosis: implications for adherence. An expert opinion from the United Arab Emirates.
J. Inshasi, A. Almadani, Sarmad Al Fahad, S. Noori +5 more
2020Neurodegenerative Disease Management9 citations Open access
Semantic Scholar
Consensus Recommendations for the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorders (NMOSD): The MENACTRIMS Guidelines
B. Yamout, R. Gouider, R. Alroughani, S. Aljarallah +17 more
2026CNS Drugs8 citations
Semantic Scholar
Factors that Can Help Select the Timing for Decompressive Hemicraniectomy for Malignant MCA Stroke
Saddat Kamran, A. Salam, N. Akhtar, A. Alboudi +7 more
2018Translational Stroke Research8 citations
Semantic Scholar
Neuromyelitis optica spectrum disorders in the Arabian Gulf: challenges and growing experience
R. Alroughani, N. Qadi, J. Inshasi, E. Shosha
2020Multiple Sclerosis Journal - Experimental, Translational and Clinical7 citations Open access
Semantic Scholar
Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Stroke: South Asian Experience.
Saadat Kamran, N. Akhtar, A. Salam, A. Alboudi +11 more
2017Journal of Stroke & Cerebrovascular Diseases7 citations
Semantic Scholar
Disease modifying treatment guidelines for multiple sclerosis in the United Arab Emirates.
Anu Jacob, A. Shatila, J. Inshasi, J. Massouh +3 more
2024Multiple Sclerosis and Related Disorders6 citations Open access
Semantic Scholar
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
J. Inshasi, S. Farouk, A. Shatila, Ali Hassan +12 more
2023Neurological Therapeutics6 citations Open access
Semantic Scholar
Real-world retrospective study of effectiveness and safety of FINgOlimod in relapsing remitting multiple sclerosis in the Middle East and North Africa (FINOMENA).
R. Alroughani, Z. Alkawi, A. Hassan, H. A. Al Otaibi +11 more
2021Clinical neurology and neurosurgery (Dutch-Flemish ed. Print)6 citations
Semantic Scholar
Correction to: How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study
C. Colosimo, D. Charles, V. P. Misra, P. Maisonobe +112 more
2019Journal of Neurology6 citations Open access
Semantic Scholar
Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study)
Hans-Peter Hartung, G. Comi, D. L. Arnold, A. Boyko +13 more
20196 citations Open access
Semantic Scholar
Intervening to reduce the risk of future disability from multiple sclerosis: are we there yet?
M. Dahdaleh, R. Alroughani, M. Aljumah, Abdulrahman Altahan +10 more
2017International Journal of Neuroscience6 citations
Semantic Scholar
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients
R. Alroughani, J. Inshasi, S. Farouk, A. Al-Asmi +12 more
2025Neurological Therapeutics5 citations Open access
Semantic Scholar
Safety and effectiveness of disease-modifying therapies after switching from natalizumab
M. Zeineddine, R. Alroughani, Samar Farouk Ahmed, S. Khoury +16 more
2024Multiple Sclerosis5 citations
Semantic Scholar
Prevalence, severity, outcomes, and risk factors of COVID-19 in multiple sclerosis: An observational study in the Middle East
R. Alroughani, J. Inshasi, J. Al-Hashel, J. Alkhaboury +4 more
2022Journal of clinical neuroscience5 citations Open access
Semantic Scholar
Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates
J. Inshasi, Sarmed A. Al-Fahad, T. Alsaadi, Ali Hassan +9 more
2021Neurological Therapeutics5 citations Open access
Semantic Scholar
Comparative effectiveness of natalizumab and anti-CD20 monoclonal antibodies in relapsing-remitting multiple sclerosis: a real-world propensity-score matched study
B. Yamout, R. Alroughani, Samar A. Mohamed, A. Al-Mahdawi +20 more
2025Journal of Neurology Neurosurgery & Psychiatry4 citations
Semantic Scholar
Practical Recommendations from the Gulf Region on the Therapeutic Use of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis: Impact of the Latest Real-World Evidence on Clinical Practice
B. Yamout, R. Alroughani, J. Inshasi, S. Farouk +16 more
2024Neurological Therapeutics4 citations Open access
Semantic Scholar
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies
Ying Li, A. Saul, B. Taylor, A. Ponsonby +152 more
2023Journal of Neurology4 citations Open access
Semantic Scholar
Real-world effectiveness and safety profile of teriflunomide in the management of multiple sclerosis in the Gulf Cooperation Council countries: An expert consensus narrative review
R. Alroughani, J. Inshasi, Mona Al Khawajah, S. Ahmed +10 more
2022Multiple Sclerosis Journal - Experimental, Translational and Clinical4 citations Open access
Semantic Scholar
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective
R. Alroughani, B. Van Wijmeersch, Jabber Al Khaboori, I. Alsharoqi +9 more
2020Therapeutic Advances in Neurological Disorders4 citations Open access
Semantic Scholar
Adaptive Neuro-Fuzzy Inference System for Prediction of Surgery Time for Ischemic Stroke Patients
Rahmani Ali, U. Qidwai, S. Ilyas, N. Akhtar +3 more
2019International Journal of Integrated Engineering4 citations Open access
Semantic Scholar
Effect of late-onset on multiple sclerosis phenotype and outcome: evidence from a multi-national registry
A. Souissi, F. Patti, T. Spelman, C. Chisari +79 more
2026Journal of Neurology3 citations Open access
Semantic Scholar
External validation of a clinical prediction model in multiple sclerosis
N. Moradi, S. Sharmin, C. Malpas, V. Shaygannejad +13 more
2022Multiple Sclerosis3 citations
Semantic Scholar
CT pattern of Infarct location and not infarct volume determines outcome after decompressive hemicraniectomy for Malignant Middle Cerebral Artery Stroke
Saddat Kamran, N. Akhtar, A. Salam, A. Alboudi +11 more
2019Scientific Reports3 citations Open access
Semantic Scholar
The real-world effectiveness and safety of off-label rituximab in a large cohort of Middle Eastern multiple sclerosis patients
Ghida Ismail, M. Zeineddine, R. Alroughani, S. Ahmed +20 more
2026Neurotherapeutics2 citations Open access
Semantic Scholar
Cost-effectiveness of ofatumumab for the treatment of relapsing forms of multiple sclerosis in the United Arab Emirates
J. Inshasi, Yomna Nowier, E. Zimovetz, Ahmed Moussa +10 more
2025Therapeutic Advances in Neurological Disorders2 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Alroughani×31
Invite
R. Alroughani — researcher profile on SciRah
B. Yamout×18
Invite
B. Yamout — researcher profile on SciRah
A. Shatila×13
Invite
A. Shatila — researcher profile on SciRah
A. Al-Asmi×11
Invite
A. Al-Asmi — researcher profile on SciRah

×9

Invite

R. Karabudak — researcher profile on SciRah

Invite

A. Boshra — researcher profile on SciRah

Invite

R. Gouider — researcher profile on SciRah

Invite

S. Khoury — researcher profile on SciRah

Invite

M. Zakaria — researcher profile on SciRah

V. Shaygannejad×8

Invite

V. Shaygannejad — researcher profile on SciRah

Invite

A. Alboudi — researcher profile on SciRah

Invite

T. Alsaadi — researcher profile on SciRah